A meta-analysis has shown that FOXP3+ Tregs have a significant negative effect on overall survival (OS) in BC patients, and are associated with estrogen and progesterone receptor status, as well as with lymph node metastases [48,49,50]. This evidence concerns the gene FOXP3 and metastatic malignant neoplasm in the lymph nodes.